Protocol No.: COG-ANBL1232

Title
COG-ANBL1232 - Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma - A Group Wide Historically Controlled Phase III Study
Principal Investigator
Paul, Stephan
Phase
NA
Age Group
Children
Applicable Disease Site
Pediatric Cancer
Participating Institution
Mary Babb Randolph Cancer Center
Contacts
Jan Rapp
Clinical Trials Manager
Phone: +1 304-293-1229
Carla Corbin, RN, BSN
Nurse Clinician
Phone: +1 304-293-1217
Denise Casino
Clinical Trials Manager
Phone: +1 304-293-0735

View on ClinicalTrials.gov